PlantFuels' strategy to drive plant-based innovation and redefine the plant supplement industry
MISSISSAUGA, ONTARIO – TheNewswire - October 26, 2021 - PlantFuel Life Inc. (CSE:FUEL) (CSE:FUEL) (OTC:PLFLF) (FSE:BR1B) ("PlantFuel" or the "Company") has announced it will begin conducting its first university study on its Performance Protein to demonstrate that it is as effective as whey protein for recovery, muscle growth and performance, which represents the latest advancements in plant-based wellness.
**PlantFuel Inc. is committed to validating their products with a strong investment in robust clinical research & development. They have sponsored a human clinical trial lead by CAHS (The Center for Applied Health Sciences), one of the premier clinical research organizations specializing in dietary supplement, sports nutrition & human performance to evaluate the safety, tolerability & efficacy of PlantFuel Performance Protein, plant-based protein in healthy, active men and women consumed daily during an 8-week exercise program.
****Using the "gold-standard" in human clinical research design with a randomized, double-blind controlled trial in 60 healthy volunteers. The study will be conducted across multiple sites (3 sites), including an NCAA Division I university.
**This trial will have research subjects randomly assigned to either PlantFuel Performance Protein or Whey Protein Isolate control product to compare how an isonitrogenous (equal amount of protein) and isoenergetic (equal total calories) plant-based protein that is augmented with additional vegan BCAAs and an apoptogenic mushroom blend (PeakO2®) influences muscle strength, endurance/ stamina, body composition (muscle to fat ratio), recovery and digestive tolerability.
****Additionally, a subset of research volunteers will be assessed for the effect of PlantFuel Performance Protein on blood essential amino acid bioavailability.
PlantFuel's Performance Protein delivers 20g of complete, Plant Fueled protein with added vegan-fermented BCAAs as InstAminos® and PeakO2® performance mushrooms.
"What our team of physicians and scientists has created with our Performance Protein is simply revolutionary. We believe we have the first plant protein that can rival the whey protein market and give consumers a performance-based option that is plant-based," states PlantFuel founder Brad Pyatt.
Comments CAHS Partner and Principal Medical/Scientific Advisor Hector Lopez, MD, CSCS, FISSN, "We welcome the opportunity to collaborate with PlantFuel via this SRA to build a body of evidence substantiating the safety and efficacy of their plant-based finished products for supporting peak exercise performance, recovery and promoting healthy adaptations to an active lifestyle. We commend PlantFuel for investing heavily in assuring all stakeholders that the commercial finished products purchased by consumers are evaluated for safety and efficacy via human clinical trials. This work will provide critical elements of their education, marketing, sales and risk management platforms."
CAHS CEO Tim Ziegenfuss, PhD, CSCS, FISSN, states, "Our SRA initiative was rolled out precisely for brands such as PlantFuel, whose leaders understand the value of utilizing what we call a ‘Halo of Science' as a bedrock principle in their mission to provide plant-based performance nutrition products that may rival conventional dairy/animal products that already have a strong evidence base.
"One of the initial clinical trials we're designing will compare a standard whey protein supplement head-to-head with a PlantFuel protein blend formulated with other bioactive ingredients, such as an adaptogenic mushroom blend and vegan fermented BCAAs, to bridge some gaps in standard vegan protein supplements."
About PlantFuel Life Inc.
PlantFuel Life Inc is a scientifically focused plant-based wellness company managed by a group of successful entrepreneurs who have extensive experience in the areas of consumer packaged goods, manufacturing, logistics, and distribution. FUEL is a CPG life science company focused on the plant-based foods and supplements industry. https://plantfuel.com/
The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2021 TheNewswire - All rights reserved.
PlantFuels推动植物性创新和重新定义植物补充剂行业的战略
安大略省密西索加-新闻通讯社-2021年10月26日-PlantFuel Life Inc.(CSE:燃料)(CSE:燃料)(场外交易代码:PLFLF)(证券交易所代码:BR1B)(“PlantFuel”或“公司”)该公司宣布,将开始对其性能蛋白进行首次大学研究,以证明其在恢复、肌肉生长和性能方面与乳清蛋白一样有效,这代表了植物性健康的最新进展。
*PlantFuel Inc.致力于通过对强大的临床研究和开发进行强有力的投资来验证他们的产品。他们赞助了一项由CAHS(应用健康科学中心)牵头的人体临床试验,CAHS是专门研究膳食补充剂、运动营养和人体性能的一流临床研究机构之一,目的是评估PlantFuel Performance Protein(植物性蛋白质)在为期8周的锻炼计划中每日摄入的健康、活跃的男性和女性的安全性、耐受性和有效性。
*使用人类临床研究设计中的“黄金标准”,对60名健康志愿者进行随机、双盲对照试验。这项研究将在多个地点(3个地点)进行,包括NCAA第一分部的一所大学。
**这项试验将随机分配给PlantFuel性能蛋白或乳清蛋白分离对照产品的研究对象,以比较等氮(等量蛋白质)和等能(等量的总卡路里)植物性蛋白质,添加额外的素食支链氨基酸和可致凋亡的蘑菇混合物(PeakO2®)影响肌肉力量、耐力/耐力、身体成分(肌肉与脂肪的比率)、恢复和消化耐受性。
*此外,还将评估一部分研究志愿者PlantFuel性能蛋白对血液必需氨基酸生物利用度的影响。
PlantFuel的Performance Protein提供20g完整的植物燃料蛋白质,并添加素食发酵的BCAA,如InstAminos®和PeakO2®Performance蘑菇。
PlantFuel创始人布拉德·派亚特说:“我们的医生和科学家团队用我们的性能蛋白创造出的东西简直是革命性的。我们相信我们拥有第一种可以与乳清蛋白市场相匹敌的植物蛋白,并为消费者提供了一种以植物为基础的性能选择。”
CAHS合伙人兼首席医学/科学顾问Hector Lopez,医学博士,CSCS,FISSN评论说:“我们很高兴有机会通过这个SRA与PlantFuel合作,建立一系列证据,证明他们的植物性成品在支持最佳运动表现、恢复和促进健康适应积极生活方式方面的安全性和有效性。我们赞扬PlantFuel投入巨资,向所有利益相关者保证,消费者购买的商业成品通过人体临床试验进行安全性和有效性评估。这项工作将为他们提供关键要素
CAHS首席执行官Tim Ziegenfuss博士,CSCS,FISSN表示:“我们的SRA计划正是为PlantFuel等品牌推出的,这些品牌的领导者明白利用我们所说的‘科学光环’作为一项基本原则的价值,他们的使命是提供以植物为基础的高性能营养产品,这些产品可能会与已经有强有力证据的传统乳制品/动物性产品相媲美。
我们正在设计的一项初步临床试验将把标准乳清蛋白补充剂与PlantFuel蛋白混合蛋白与其他生物活性成分(如具有适应性的蘑菇混合物和素食发酵支链氨基酸)进行正面比较,以弥补标准素食蛋白补充剂中的一些空白。“
PlantFuel Life Inc.简介
PlantFuel Life Inc是一家专注于科学的植物性保健公司,由一群在消费品、制造、物流和分销领域拥有丰富经验的成功企业家管理。Fuel是一家CPG生命科学公司,专注于植物性食品和补充剂行业。Https://plantfuel.com/
加拿大证券交易所(“CSE“)既不批准也不反对本新闻稿的内容。CSE及其市场监管机构(该词在CSE的政策中定义)均不对本新闻稿的充分性或准确性承担责任。
版权所有(C)2021 TheNewswire-保留所有权利。